Santero Therapeutics

Belgium
Charleroi, Wallonia, Belgium, 6041

Company profile

Santero Therapeutics company profile

Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2021-01-01, Year

Headquarters

Postal code
6041
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$8.6M
Last funding
Series A / $8.6M / 2023-06-07
Last equity funding
Series A / $8.6M
Investors
5
Lead investors
1
Founders
2
Articles
1

Founders and investors

Founders

Abel Garcia-PinoCédric Govaerts

Lead investors

Newton Biocapital

Investors

Newton BiocapitalPierre DrionSambrinvestSFPIMS.R.I.W.